Although the GIP and GIP receptor system is known to promote energy assimilation and contribute to obesity [26], the fact that a dual GIP/GLP-1R agonist exhibited stronger anti-obesity effects than GLP-1RAs alone was unexpected. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.